Ultomiris (Ravulizumab-Cwvz) FDA-Approved for Generalized MG Patients
The FDA has just approved Ultomiris (Ravulizumab-Cwvz). It is effective for adults diagnosed with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive.
What are your thoughts? Will you be reaching out to your doctor or mentioning if this treatment could be possible for you at your next appointment?
Log in to reply.